{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:53:38Z","timestamp":1769043218561,"version":"3.49.0"},"reference-count":67,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:00:00Z","timestamp":1718755200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003093","name":"Malaysian Ministry of Education","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Fundamental Research Grant Scheme","award":["FRGS\/1\/2018\/SKK08\/PERDANA\/03\/1"],"award-info":[{"award-number":["FRGS\/1\/2018\/SKK08\/PERDANA\/03\/1"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disorder due to deletion or mutation of survival motor neuron 1 (SMN1) gene. Although survival motor neuron 2 (SMN2) gene is still present in SMA patients, the production of full-length survival motor neuron (SMN) protein is insufficient owing to missing or mutated SMN1. No current disease-modifying therapies can cure SMA. The aim of this study was to explore microRNA (miRNA)-based therapies that may serve as a potential target for therapeutic intervention in delaying SMA progression or as treatment. The study screened for potentially dysregulated miRNAs in SMA fibroblast-derived iPSCs using miRNA microarray. Results from the miRNA microarray were validated using quantitative reverse transcription polymerase chain reaction. Bioinformatics analysis using various databases was performed to predict the potential putative gene targeted by hsa-miR-663a. The findings showed differential expression of hsa-miR-663a in SMA patients in relation to a healthy control. Bioinformatics analysis identified GNG7, IGF2, and TNN genes that were targeted by hsa-miR-663a to be involved in the PI3K-AKT pathway, which may be associated with disease progression in SMA. Thus, this study suggests the potential role of hsa-miR-663a as therapeutic target for the treatment of SMA patients in the near future.<\/jats:p>","DOI":"10.1093\/jnen\/nlae065","type":"journal-article","created":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T06:53:50Z","timestamp":1718780030000},"page":"822-832","source":"Crossref","is-referenced-by-count":2,"title":["Revealing the potential role of hsa-miR-663a in modulating the PI3K-Akt signaling pathway via miRNA microarray in spinal muscular atrophy patient fibroblast-derived iPSCs"],"prefix":"10.1093","volume":"83","author":[{"given":"Gayatri","family":"Gandhi","sequence":"first","affiliation":[{"name":"Perdana University Graduate School of Medicine, Perdana University , Kuala Lumpur, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radha","family":"Kodiappan","sequence":"additional","affiliation":[{"name":"Department of Research and Training, MAHSA Specialist Hospital , Selangor, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syahril","family":"Abdullah","sequence":"additional","affiliation":[{"name":"Medical Genetics Laboratory, Department of Biomedical Sciences, Faculty of Medicine & Health Sciences, Universiti Putra Malaysia , Selangor, Malaysia"},{"name":"Genetics & Regenerative Medicine Research Group, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia , Selangor, Malaysia"},{"name":"Malaysia Genome and Vaccine Institute, National Institutes of Biotechnology Malaysia , Selangor, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoon Koon","family":"Teoh","sequence":"additional","affiliation":[{"name":"Centre for Stem Cell Research, M. Kandiah Faculty of Medicine and Health Sciences, Universiti Tunku Abdul Rahman , Selangor, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihui","family":"Tai","sequence":"additional","affiliation":[{"name":"Centre for Stem Cell Research, M. Kandiah Faculty of Medicine and Health Sciences, Universiti Tunku Abdul Rahman , Selangor, Malaysia"},{"name":"Cytopeutics Sdn. Bhd , Selangor, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soon Keng","family":"Cheong","sequence":"additional","affiliation":[{"name":"Centre for Stem Cell Research, M. Kandiah Faculty of Medicine and Health Sciences, Universiti Tunku Abdul Rahman , Selangor, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5028-9293","authenticated-orcid":false,"given":"Wendy Wai Yeng","family":"Yeo","sequence":"additional","affiliation":[{"name":"Perdana University Graduate School of Medicine, Perdana University , Kuala Lumpur, Malaysia"},{"name":"School of Pharmacy, Monash University Malaysia , Selangor Darul Ehsan, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,6,18]]},"reference":[{"issue":"23","key":"2024092007512277600_nlae065-B1","doi-asserted-by":"crossref","first-page":"8691","DOI":"10.1523\/JNEUROSCI.0417-15.2015","article-title":"Disease mechanisms and therapeutic approaches in spinal muscular atrophy","volume":"35","author":"Tisdale","year":"2015","journal-title":"J Neurosci"},{"issue":"4","key":"2024092007512277600_nlae065-B2","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.ncl.2015.07.004","article-title":"Spinal muscular atrophy","volume":"33","author":"Kolb","year":"2015","journal-title":"Neurol Clin"},{"issue":"1","key":"2024092007512277600_nlae065-B3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and characterization of a spinal muscular atrophy-determining gene","volume":"80","author":"Lefebvre","year":"1995","journal-title":"Cell"},{"issue":"3","key":"2024092007512277600_nlae065-B4","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.0.CO;2-9","article-title":"An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA)","volume":"15","author":"Wirth","year":"2000","journal-title":"Hum Mutat"},{"key":"2024092007512277600_nlae065-B5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.brainres.2012.01.044","article-title":"Spinal muscular atrophy: the role of SMN in axonal mRNA regulation","volume":"1462","author":"Fallini","year":"2012","journal-title":"Brain Res"},{"issue":"15","key":"2024092007512277600_nlae065-B6","doi-asserted-by":"crossref","first-page":"6501","DOI":"10.1021\/acs.jmedchem.8b00741","article-title":"Discovery of risdiplam, a selective survival of motor neuron-2 (SMN2) gene splicing modifier for the treatment of spinal muscular atrophy (SMA)","volume":"61","author":"Ratni","year":"2018","journal-title":"J Med Chem"},{"issue":"8","key":"2024092007512277600_nlae065-B7","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1177\/0883073807305673","article-title":"Spinal muscular atrophy: clinical classification and disease heterogeneity","volume":"22","author":"Russman","year":"2007","journal-title":"J Child Neurol"},{"issue":"2","key":"2024092007512277600_nlae065-B8","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/338627","article-title":"Quantitative analyses of SMN1 and SMN2 based on real-time lightcycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy","volume":"70","author":"Feldk\u00f6tter","year":"2002","journal-title":"Am J Hum Genet"},{"key":"2024092007512277600_nlae065-B9","doi-asserted-by":"crossref","first-page":"592234","DOI":"10.3389\/fphar.2020.592234","article-title":"Drug screening and drug repositioning as promising therapeutic approaches for spinal muscular atrophy treatment","volume":"11","author":"Menduti","year":"2020","journal-title":"Front Pharmacol"},{"issue":"51","key":"2024092007512277600_nlae065-B10","doi-asserted-by":"crossref","first-page":"35375","DOI":"10.1021\/acsomega.1c04688","article-title":"Spinal muscular atrophy patient iPSC-derived motor neurons display altered proteomes at early stages of differentiation","volume":"6","author":"Varderidou-Minasian","year":"2021","journal-title":"ACS Omega"},{"key":"2024092007512277600_nlae065-B11","doi-asserted-by":"crossref","first-page":"117485","DOI":"10.1016\/j.jns.2021.117485","article-title":"The potential role of miRNA therapies in spinal muscle atrophy","volume":"427","author":"Gandhi","year":"2021","journal-title":"J Neurol Sci"},{"key":"2024092007512277600_nlae065-B12","doi-asserted-by":"crossref","first-page":"1226969","DOI":"10.3389\/fneur.2023.1226969","article-title":"Role of circulating biomarkers in spinal muscular atrophy: insights from a new treatment era","volume":"14","author":"Giorgia","year":"2023","journal-title":"Front Neurol"},{"issue":"2","key":"2024092007512277600_nlae065-B13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"issue":"9","key":"2024092007512277600_nlae065-B14","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/ng.905","article-title":"MicroRNAs can generate thresholds in target gene expression","volume":"43","author":"Mukherji","year":"2011","journal-title":"Nat Genet"},{"issue":"7209","key":"2024092007512277600_nlae065-B15","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nature07228","article-title":"Widespread changes in protein synthesis induced by microRNAs","volume":"455","author":"Selbach","year":"2008","journal-title":"Nature"},{"issue":"23","key":"2024092007512277600_nlae065-B16","doi-asserted-by":"crossref","first-page":"6318","DOI":"10.1093\/hmg\/ddu350","article-title":"SMN regulates axonal local translation via miR-183\/mTOR pathway","volume":"23","author":"Kye","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"12","key":"2024092007512277600_nlae065-B17","doi-asserted-by":"crossref","first-page":"e0008889","DOI":"10.1371\/journal.pntd.0008889","article-title":"MiRNAs may play a major role in the control of gene expression in key pathobiological processes in chagas disease cardiomyopathy","volume":"14","author":"Laugier","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"2024092007512277600_nlae065-B18","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1073\/pnas.0707594105","article-title":"MicroRNA-373 induces expression of genes with complementary promoter sequences","volume":"105","author":"Place","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"2024092007512277600_nlae065-B19","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/jcmm.13450","article-title":"miRNA in spinal muscular atrophy pathogenesis and therapy","volume":"22","author":"Magri","year":"2018","journal-title":"J Cell Mol Med"},{"issue":"1","key":"2024092007512277600_nlae065-B20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ncrna.2018.12.001","article-title":"Dysregulation of microRNA metabolism in motor neuron diseases: novel biomarkers and potential therapeutics","volume":"4","author":"De Paola","year":"2018","journal-title":"Noncoding RNA Res"},{"issue":"5","key":"2024092007512277600_nlae065-B21","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.stemcr.2022.03.019","article-title":"Functional genomics and the future of iPSCs in disease modeling","volume":"17","author":"Brooks","year":"2022","journal-title":"Stem Cell Rep"},{"issue":"3","key":"2024092007512277600_nlae065-B22","first-page":"325","article-title":"Reprogramming human dermal fibroblast into induced pluripotent stem cells using non-integrative Sendai virus for transduction","volume":"40","author":"Tai","year":"2018","journal-title":"Malays J Pathol"},{"key":"2024092007512277600_nlae065-B23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fnagi.2018.00041","article-title":"MicroRNA-455-3p as a potential biomarker for Alzheimer\u2019s disease: an update","volume":"10","author":"Kumar","year":"2018","journal-title":"Front Aging Neurosci"},{"issue":"Database issue","key":"2024092007512277600_nlae065-B24","doi-asserted-by":"crossref","first-page":"D140","DOI":"10.1093\/nar\/gkj112","article-title":"miRBase: microRNA sequences, targets and gene nomenclature","volume":"34","author":"Griffiths-Jones","year":"2006","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"2024092007512277600_nlae065-B25","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/s41419-018-0925-y","article-title":"MALAT1\u2013miR663a negative feedback loop in colon cancer cell functions through direct miRNA\u2013lncRNA binding","volume":"9","author":"Tian","year":"2018","journal-title":"Cell Death Dis"},{"issue":"2","key":"2024092007512277600_nlae065-B26","doi-asserted-by":"crossref","first-page":"e1651","DOI":"10.1038\/cddis.2015.10","article-title":"APP intracellular domain acts as a transcriptional regulator of miR-663 suppressing neuronal differentiation","volume":"6","author":"Shu","year":"2015","journal-title":"Cell Death Dis"},{"issue":"10","key":"2024092007512277600_nlae065-B27","first-page":"1","article-title":"Fluoxetine increases the expression of miR-572 and miR-663a in human neuroblastoma cell lines","volume":"11","author":"Vasu","year":"2016","journal-title":"PLoS ONE"},{"issue":"12","key":"2024092007512277600_nlae065-B28","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.3390\/ijms19123725","article-title":"PI3K signaling in neurons: a central node for the control of multiple functions","volume":"19","author":"S\u00e1nchez-Alegr\u00eda","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2024092007512277600_nlae065-B29","doi-asserted-by":"crossref","first-page":"e39113","DOI":"10.1371\/journal.pone.0039113","article-title":"Inhibition of apoptosis blocks human motor neuron cell death in a stem cell model of spinal muscular atrophy","volume":"7","author":"Sareen","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"2024092007512277600_nlae065-B30","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1044-7431(03)00012-5","article-title":"Tenascin-N: characterization of a novel member of the tenascin family that mediates neurite repulsion from hippocampal explants","volume":"23","author":"Neidhardt","year":"2003","journal-title":"Mol Cell Neurosci"},{"key":"2024092007512277600_nlae065-B31","doi-asserted-by":"crossref","first-page":"25960","DOI":"10.1038\/srep25960","article-title":"Differential neuronal vulnerability identifies IGF-2 as a protective factor in ALS","volume":"6","author":"Allodi","year":"2016","journal-title":"Sci Rep"},{"issue":"2","key":"2024092007512277600_nlae065-B32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells9020276","article-title":"miRNAs as biomarkers in disease: latest findings regarding their role in diagnosis and prognosis","volume":"9","author":"Condrat","year":"2020","journal-title":"Cells"},{"issue":"1","key":"2024092007512277600_nlae065-B33","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s43094-022-00413-9","article-title":"Recent trends in miRNA therapeutics and the application of plant miRNA for prevention and treatment of human diseases","volume":"8","author":"Saiyed","year":"2022","journal-title":"Futur J Pharm Sci"},{"issue":"9","key":"2024092007512277600_nlae065-B34","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.1074\/jbc.M707304200","article-title":"In vitro and in cellulo evidences for association of the survival of motor neuron complex with the fragile X mental retardation protein","volume":"283","author":"Piazzon","year":"2008","journal-title":"J Biol Chem"},{"issue":"4","key":"2024092007512277600_nlae065-B35","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/hmg\/ddm327","article-title":"KH-type splicing regulatory protein interacts with survival motor neuron protein and is misregulated in spinal muscular atrophy","volume":"17","author":"Tadesse","year":"2008","journal-title":"Hum Mol Genet"},{"issue":"29","key":"2024092007512277600_nlae065-B36","doi-asserted-by":"crossref","first-page":"13111","DOI":"10.1073\/pnas.1006151107","article-title":"miRNA malfunction causes spinal motor neuron disease","volume":"107","author":"Haramati","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024092007512277600_nlae065-B37","doi-asserted-by":"crossref","first-page":"e50848","DOI":"10.7554\/eLife.50848","article-title":"Multifaceted roles of microRNAs: from motor neuron generation in embryos to degeneration in spinal muscular atrophy","volume":"8","author":"Chen","year":"2019","journal-title":"Elife"},{"key":"2024092007512277600_nlae065-B38","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.omtn.2023.03.005","article-title":"MiR34 contributes to spinal muscular atrophy and AAV9-mediated delivery of MiR34a ameliorates the motor deficits in SMA mice","volume":"32","author":"Chen","year":"2023","journal-title":"Mol Ther Nucleic Acids"},{"issue":"11","key":"2024092007512277600_nlae065-B39","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1093\/hmg\/ddw084","article-title":"Cell-type-specific miR-431 dysregulation in a motor neuron model of spinal muscular atrophy","volume":"25","author":"Wertz","year":"2016","journal-title":"Hum Mol Genet"},{"issue":"7","key":"2024092007512277600_nlae065-B40","doi-asserted-by":"crossref","first-page":"e331","DOI":"10.1038\/mtna.2016.47","article-title":"Altered levels of microRNA-9, -206, and -132 in spinal muscular atrophy and their response to antisense oligonucleotide therapy","volume":"5","author":"Catapano","year":"2016","journal-title":"Mol Ther Nucleic Acids"},{"issue":"9","key":"2024092007512277600_nlae065-B41","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.3727\/096368909X471224","article-title":"MicroRNAs regulation modulated self-renewal and lineage differentiation of stem cells","volume":"18","author":"Liu","year":"2009","journal-title":"Cell Transplant"},{"issue":"1","key":"2024092007512277600_nlae065-B42","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.stem.2010.06.012","article-title":"MicroRNAs as regulators of differentiation and cell fate decisions","volume":"7","author":"Ivey","year":"2010","journal-title":"Cell Stem Cell"},{"key":"2024092007512277600_nlae065-B43","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3389\/fncel.2014.00175","article-title":"MicroRNAs: key triggers of neuronal cell fate","volume":"8","author":"Meza-Sosa","year":"2014","journal-title":"Front Cell Neurosci"},{"issue":"12","key":"2024092007512277600_nlae065-B44","first-page":"5226","article-title":"Aberrant expression of microRNAs in serum may identify individuals with pancreatic cancer","volume":"7","author":"Lin","year":"2014","journal-title":"Int J Clin Exp Med"},{"issue":"6","key":"2024092007512277600_nlae065-B45","doi-asserted-by":"crossref","first-page":"152411","DOI":"10.1016\/j.prp.2019.04.003","article-title":"Identification of circulating miR-663a as a potential biomarker for diagnosing osteosarcoma","volume":"215","author":"Huang","year":"2019","journal-title":"Pathol Res Pract"},{"issue":"1","key":"2024092007512277600_nlae065-B46","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/s12885-016-2350-x","article-title":"MicroRNA-663a is downregulated in non-small cell lung cancer and inhibits proliferation and invasion by targeting JunD","volume":"16","author":"Zhang","year":"2016","journal-title":"BMC Cancer"},{"key":"2024092007512277600_nlae065-B47","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3389\/fnmol.2018.00106","article-title":"Differential expression of several miRNAs and the host genes AATK and DNM2 in leukocytes of sporadic ALS patients","volume":"11","author":"Vrabec","year":"2018","journal-title":"Front Mol Neurosci"},{"issue":"4","key":"2024092007512277600_nlae065-B48","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1161\/CIRCRESAHA.111.247437","article-title":"Differential expression of microRNAs in different disease states","volume":"110","author":"Abdellatif","year":"2012","journal-title":"Circ Res"},{"issue":"10","key":"2024092007512277600_nlae065-B49","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1111\/j.1742-4658.2010.07643.x","article-title":"Nuclear factor TDP-43 can affect selected microRNA levels","volume":"277","author":"Buratti","year":"2010","journal-title":"FEBS J"},{"issue":"6","key":"2024092007512277600_nlae065-B50","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ygeno.2012.08.006","article-title":"MiRNA_Targets: a database for miRNA target predictions in coding and non-coding regions of mRNAs","volume":"100","author":"Kumar","year":"2012","journal-title":"Genomics"},{"issue":"Suppl(6S)","key":"2024092007512277600_nlae065-B51","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1038\/ng1798","article-title":"MicroRNA target predictions in animals","volume":"38","author":"Rajewsky","year":"2006","journal-title":"Nat Genet"},{"issue":"5","key":"2024092007512277600_nlae065-B52","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1161\/CIRCRESAHA.112.276717","article-title":"Targeting msicroRNA targets","volume":"111","author":"Da Costa Martins","year":"2012","journal-title":"Circ Res"},{"issue":"136","key":"2024092007512277600_nlae065-B53","first-page":"57786","article-title":"Biotin-based pulldown assay to validate mRNA targets of cellular miRNAs","author":"Dash","year":"2018","journal-title":"J Vis Exp"},{"key":"2024092007512277600_nlae065-B54","first-page":"1993","volume-title":"GeneReviews\u00ae [Internet].","author":"Ortiz-Gonzalez","year":"2020"},{"issue":"7","key":"2024092007512277600_nlae065-B55","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nn.4561","article-title":"Reduced sensory synaptic excitation impairs motor neuron function via Kv2.1 in spinal muscular atrophy","volume":"20","author":"Fletcher","year":"2017","journal-title":"Nat Neurosci"},{"issue":"2","key":"2024092007512277600_nlae065-B56","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s13353-011-0079-4","article-title":"Loss of protein expression and recurrent DNA hypermethylation of the GNG7 gene in squamous cell carcinoma of the head and neck","volume":"53","author":"Hartmann","year":"2012","journal-title":"J Appl Genet"},{"issue":"2-3","key":"2024092007512277600_nlae065-B57","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.brainresrev.2003.11.002","article-title":"The insulin-like growth factor-II\/mannose-6-phosphate receptor: structure, distribution and function in the central nervous system","volume":"44","author":"Hawkes","year":"2004","journal-title":"Brain Res Brain Res Rev"},{"issue":"3","key":"2024092007512277600_nlae065-B58","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000343995","article-title":"Insulin-like growth factor 2 in development and disease: a mini-review","volume":"59","author":"Bergman","year":"2013","journal-title":"Gerontology"},{"issue":"Pt 3","key":"2024092007512277600_nlae065-B59","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1242\/jcs.022566","article-title":"PLD regulates myoblast differentiation through the mTOR-IGF2 pathway","volume":"121","author":"Yoon","year":"2008","journal-title":"J Cell Sci"},{"key":"2024092007512277600_nlae065-B60","doi-asserted-by":"crossref","first-page":"209736","DOI":"10.1155\/2011\/209736","article-title":"Targeting the insulin-like growth factor pathway in rhabdomyosarcomas: rationale and future perspectives","volume":"2011","author":"Martins","year":"2011","journal-title":"Sarcoma"},{"issue":"7","key":"2024092007512277600_nlae065-B61","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1017\/S1041610219000383","article-title":"Genome-wide RNA sequencing analysis reveals that IGF-2 attenuates memory decline, oxidative stress and amyloid plaques in an Alzheimer\u2019s disease mouse model (AD) by activating the PI3K\/AKT\/CREB signaling pathway","volume":"31","author":"Xia","year":"2019","journal-title":"Int Psychogeriatr"},{"issue":"1","key":"2024092007512277600_nlae065-B62","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7599\/hmr.2017.37.1.18","article-title":"The role of PI3K\/AKT pathway and its therapeutic possibility in Alzheimer\u2019s disease","volume":"37","author":"Yu","year":"2017","journal-title":"Hanyang Med Rev"},{"issue":"1","key":"2024092007512277600_nlae065-B63","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41419-020-03312-0","article-title":"METTL14-regulated PI3K\/Akt signaling pathway via PTEN affects HDAC5-mediated epithelial\u2013mesenchymal transition of renal tubular cells in diabetic kidney disease","volume":"12","author":"Xu","year":"2021","journal-title":"Cell Death Dis"},{"issue":"3","key":"2024092007512277600_nlae065-B64","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0959-4388(00)00211-7","article-title":"Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway","volume":"11","author":"Brunet","year":"2001","journal-title":"Curr Opin Neurobiol"},{"issue":"34","key":"2024092007512277600_nlae065-B65","doi-asserted-by":"crossref","first-page":"12063","DOI":"10.1523\/JNEUROSCI.0608-15.2015","article-title":"IGF-1R reduction triggers neuroprotective signaling pathways in spinal muscular atrophy mice","volume":"35","author":"Biondi","year":"2015","journal-title":"J Neurosci"},{"key":"2024092007512277600_nlae065-B66","doi-asserted-by":"crossref","first-page":"105366","DOI":"10.1016\/j.nbd.2021.105366","article-title":"Intracellular pathways involved in cell survival are deregulated in mouse and human spinal muscular atrophy motoneurons","volume":"155","author":"Sansa","year":"2021","journal-title":"Neurobiol Dis"},{"issue":"1","key":"2024092007512277600_nlae065-B67","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41420-023-01409-x","article-title":"ERK MAPK signaling pathway inhibition as a potential target to prevent autophagy alterations in spinal muscular atrophy motoneurons","volume":"9","author":"Sansa","year":"2023","journal-title":"Cell Death Discov"}],"container-title":["Journal of Neuropathology &amp; Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnen\/article-pdf\/83\/10\/822\/59157590\/nlae065.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnen\/article-pdf\/83\/10\/822\/59157590\/nlae065.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T07:52:06Z","timestamp":1726818726000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnen\/article\/83\/10\/822\/7696000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,18]]},"references-count":67,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,6,18]]},"published-print":{"date-parts":[[2024,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jnen\/nlae065","relation":{},"ISSN":["0022-3069","1554-6578"],"issn-type":[{"value":"0022-3069","type":"print"},{"value":"1554-6578","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,10]]},"published":{"date-parts":[[2024,6,18]]}}}